Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Journey Medical | DERM | 7. nov 2024 | 5.71 | +4.96 |
Jowell Global | JWEL | 7. nov 2024 | 2.02 | +5.76 |
JOYY ADR | YY | 7. nov 2024 | 34.34 | +1.00 |
JP Morgan Chase | JPM | 7. nov 2024 | 236.38 | -4.32 |
JP Morgan Chase & Co EE Pref | JPM-C | 7. nov 2024 | 25.41 | +0.16 |
JP Morgan Chase & Co GG Pref | JPM-J | 7. nov 2024 | 22.58 | +0.71 |
JP Morgan Chase & Co Ser DD Pref | JPM-D | 7. nov 2024 | 25.22 | +0.08 |
JPMorgan Nasdaq Equity Premium Income ETF | JEPQ | 7. nov 2024 | 56.43 | +0.84 |
Jumia Technologies ADR | JMIA | 7. nov 2024 | 4.00 | -17.01 |
Junee Limited - Ordinary Shares | JUNE | 7. nov 2024 | 4.90 | -1.21 |
Junior Gold Miners ETF Market Vectors | GDXJ | 7. nov 2024 | 50.32 | +2.69 |
Juniper Networks | JNPR | 7. nov 2024 | 39.00 | -0.03 |
JVSPAC Acquisition | JVSA | 7. nov 2024 | 10.38 | 0.00 |
JVSPAC Acquisition | JVSAU | 7. nov 2024 | 10.90 | 0.00 |
JX Luxventure | JXJT | 7. nov 2024 | 1.28 | -0.78 |
Kadant | KAI | 7. nov 2024 | 387.14 | +0.51 |
Kairos Pharma | KAPA | 7. nov 2024 | 1.37 | 0.00 |
Kairous Acquisition | KACL | 7. nov 2024 | 12.30 | 0.00 |
Kaiser Aluminium | KALU | 7. nov 2024 | 83.53 | -3.10 |
Kaival Brands Innovations Group | KAVL | 7. nov 2024 | 0.90 | -1.65 |
Kaixin Holdings | KXIN | 7. nov 2024 | 3.60 | -6.25 |
Kala Bio | KALA | 7. nov 2024 | 6.87 | -2.55 |
Kaltura | KLTR | 7. nov 2024 | 1.89 | +9.25 |
KalVista Pharmaceuticals | KALV | 7. nov 2024 | 11.18 | -2.02 |
Kamada | KMDA | 7. nov 2024 | 5.98 | -0.17 |
Kandi Technologies Group | KNDI | 7. nov 2024 | 1.37 | +6.20 |
Kanzhun ADR | BZ | 7. nov 2024 | 15.33 | +3.58 |
Karat Packaging | KRT | 7. nov 2024 | 29.35 | -1.01 |
Karooooo | KARO | 7. nov 2024 | 39.56 | -3.21 |
Kartoon Studios | TOON | 7. nov 2024 | 0.73 | +1.04 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.